Advertisement
Advertise here Publish your press releases here Sponsor BioPortfolio
Follow us on Twitter Sign up for daily news and research emails Contributors wanted

Selecta Biosciences, Inc. Company Profile

04:19 EDT 28th July 2014 | BioPortfolio

Selecta Biosciences, Inc. is a biopharmaceutical company developing an entirely new class of targeted vaccines that induces an antigen-specific immune activation or antigen-specific immune tolerance for therapeutic and prophylactic applications. Selecta's proprietary Synthetic Vaccine Particle (SVP™) platform creates a new paradigm in vaccine development, enabling completely new therapeutic applications while offering the potential of improved efficacy and safety profiles. Selecta’s fully synthetic engineering of novel vaccines offers a number of compelling benefits, including flexible modular vaccine design and accelerated development timelines using robust manufacturing processes. Selecta’s SVP™ platform technology is flexible to enable diverse vaccines and the company has created targeted antigen-specific Synthetic Vaccine Particles (tSVP™) and targeted antigen-specific tolerogenic Synthetic Vaccine Particles (t2SVP™).


News Articles [580 Associated News Articles listed on BioPortfolio]

3SBio licenses pegsiticase to Selecta Biosciences to develop the gout drug candidate

China-based biotech firm 3SBio has entered into an exclusive license with Selecta Biosciences for pegsiticase (Uricase PEG-20), a pegylated recombinant uricase from candida utilis.

3SBio licenses Pegsiticase to Selecta Biosciences to develop new drug for Gout treatment

3SBio, a China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, has announced that it has entered into an exclusive license with...

3SBio signs exclusive license agreement with Selecta Biosciences for pegsiticase

3SBio Inc., a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced it has entered into an exclusive lic...

Selecta Biosciences, 3SBio ink agreement for gout

Selecta Biosciences, a clinical stage biotechnology company developing a novel class of targeted antigen-specific immune tolerance treatments, has entered into an exclusive license with 3SBio, a biote...

3SBio and Selecta sign a biotech deal for gout

Selecta Biosciences has entered into an exclusive biotech deal to license with 3SBio for pegsiticase (Uricase PEG-20), a pegylated recombinant uricase from candida utilis. Pegsiticase has shown the ab...

3SBio and US-based Selecta Forge Deal on Gout Treatment

3SBio of China out-licensed rights for its gout treatment to Selecta Biosciences, a US clinical stage company that develops antigen-specific immune treatments. Selecta intends to apply its Synthetic V...

3SBio grants Selecta rights to pegsiticase

Chinese biotech 3SBio Inc. licensed Selecta Biosciences Inc. (immunomodulatory therapeutics and vaccines) exclusive US and European development rights to pegsiticase, a Phase I pegylated recombinant u...

3SBio Gives Selecta Exclusive License To Develop Gout Drug

China's 3SBio and Selecta Biosciences have reached an agreement giving the U.S. drug maker an exclusive license to develop Uricase PEG-20 (pegsiticase) for treating gout.

Drugs and Medications [13 Associated Drugs and Medications listed on BioPortfolio]

Naturally nova scotia hand sanitizer [Owen Biosciences, Inc.]

Drug Facts

Anhydrous spf 30 [Owen Biosciences, Inc.]

Drug Facts

Anhydrous spf 30 [Owen Biosciences, Inc.]

Drug Facts

Natelle one [Azur Pharma, Inc.]

Natelle OneRx Prenatal Vitamin & Plant-Based DHA Now with 28 mg Iron

Natelle one [Azur Pharma, Inc.]

Natelle®OneRx Prenatal Vitamin & Plant-Based DHA

PubMed Articles [41 Associated PubMed Articles listed on BioPortfolio]

Back cover.

Contents list.

Front cover.

Inside front cover.

China Plans Large Center for PDX Models.

The Chinese Academy of Sciences' Shanghai Institute of Materia Medica will collaborate with Crown Biosciences to build a collection of about 4,000 patient-derived xenograft models that will aid cancer...

Clinical Trials [2 Associated Clinical Trials listed on BioPortfolio]

Treatment of Alveolar Bone Defects Using Aastrom Biosciences Autologous Tissue Repair Cell Therapy

The purpose of this research is to determine if a subject's own bone marrow tissue can help regenerate bone in the area of his/her jaw where a tooth has been removed using Tissue Repair Ce...

Identification of Predictive Factors for Survival of Patients With Recurrent Prostate Cancer From Clinical Features, Tissue Image Features and Molecular Biomarker Data

We seek to improve the predictive accuracy of the nomogram to predict survival for patients with castrate mets disease through the addition of pathological data, the results of automated m...

Companies [293 Associated Companies listed on BioPortfolio]

Selecta Biosciences, Inc.

Selecta Biosciences, Inc. is a biopharmaceutical company developing an entirely new class of targeted vaccines that induces an antigen-specific immune activation or antigen...

Hydra Biosciences, Inc.

Hydra Biosciences is a privately-held biopharmaceutical company based in Cambridge, Massachusetts, and develops drugs to treat pain, inflammation, anxiety and other diseases using...

Valent BioSciences Corporation

Headquartered in Libertyville, IL, Valent BioSciences is a subsidiary of Tokyo-based Sumitomo Chemical Company and is the worldwide leader in the development, manufacturing and co...

JeNu Biosciences

JeNu Biosciences was founded in 2008 by a team of ultrasound scientists, medical doctors and beauty executives and is currently led by Wayne Wager, CEO. JeNu Biosciences is a Seat...

DaVinci Biosciences LLC

DaVinci Biosciences LLC is a privately held company dedicated to advancing therapies that improve the quality of life for individuals suffering from trauma, disease and degenerative disorders. Through...

More Information about "Selecta Biosciences, Inc." on BioPortfolio

We have published hundreds of Selecta Biosciences, Inc. news stories on BioPortfolio along with dozens of Selecta Biosciences, Inc. Clinical Trials and PubMed Articles about Selecta Biosciences, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Selecta Biosciences, Inc. Companies in our database. You can also find out about relevant Selecta Biosciences, Inc. Drugs and Medications on this site too.

Search BioPortfolio:
Advertisement

Relevant Topic

Vaccine
Latest News Clinical Trials Research Drugs Reports Corporate
A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one...

Advertisement

Corporate Database Quicklinks



Searches Linking to this Company Record